An adolescent rat model of vincristine-induced peripheral neuropathy
Childhood acute lymphoblastic leukemia (ALL) is a significant clinical problem that can be effectively treated with vincristine, a vinca alkaloid-based chemotherapeutic agent. However, nearly all children receiving vincristine treatment develop vincristine-induced peripheral neuropathy (VIPN). The i...
Main Authors: | Ai-Ling Li, Jonathon D. Crystal, Yvonne Y. Lai, Tammy J. Sajdyk, Jamie L. Renbarger, Andrea G. Hohmann |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-08-01
|
Series: | Neurobiology of Pain |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2452073X21000180 |
Similar Items
-
Treatment strategies for chemotherapy-induced peripheral neuropathy: potential role of exercise
by: Karen Y. Wonders, et al.
Published: (2011-12-01) -
Electrophysiologic Patterns of Symptomatic Vincristine-Induced Peripheral Neuropathy in Children with Acute Lymphocytic Leukemia
by: Jae-Gyeong Jeong, et al.
Published: (2023-01-01) -
The Future of Chemotherapy: The Mechanisms and Benefits of Exercise in Taxane-Induced Peripheral Neuropathy
by: Sumedha Shastry, et al.
Published: (2023-11-01) -
Therapeutics for Chemotherapy-Induced Peripheral Neuropathy: Approaches with Natural Compounds from Traditional Eastern Medicine
by: Geehoon Chung, et al.
Published: (2022-07-01) -
EFFICACY AND SAFETY OF DULOXETINE IN THE TREATMENT OF CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY: A SYSTEMATIC REVIEW AND META-ANALYSIS
by: I Putu Eka Widyadharma, et al.
Published: (2021-01-01)